Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sharon A. Minda"'
Autor:
Barbara A. Carroll, Daniel A. Yohay, Bruce Lobaugh, L. Darryl Quarles, Dorothy W. Bartholomay, Sharon A. Minda, Charles E. Spritzer
Publikováno v:
Kidney International. 45(6):1710-1721
Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. To examine the most effective route (intravenous vs. “pulse” oral), dose (physiologic vs. pharmacologic) and long-term efficacy of calcitriol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::882bc6238aee9818773dab89810278cc
Autor:
N. Reed Dunnick, Joseph S. Moss, Glenn E. Newman, Steve J. Schwab, W. Ben Vernon, Sharon A. Minda
Publikováno v:
American Journal of Kidney Diseases. 15:305-308
Tenckhoff peritoneal dialysis (PD) catheter malposition is one of the leading causes of catheter malfunction. Fluoroscopically directed stiff-wire manipulation of malpositioned PD catheters has been advocated as a method of catheter salvage. Two hund
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96daa307ed3c445b75179b3a2d5f5953
https://doi.org/10.1016/s0272-6386(12)80075-8
https://doi.org/10.1016/s0272-6386(12)80075-8
Publikováno v:
Renal failure. 22(4)
Since the earliest reports of the use of Epoetin alfa in hemodialysis patients, it has been described that Epoetin alfa may exacerbate preexisting hypertension or induce hypertension in End Stage Renal Disease (ESRD) patients not previously hypertens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbdaba59cf15aff6bde37e6922e67625
https://pubmed.ncbi.nlm.nih.gov/10901181
https://pubmed.ncbi.nlm.nih.gov/10901181
Autor:
David W. Butterly, J. Caulie Gunnells, Gregory P. Samsa, Stephen R. Smith, Frank E. Harrell, Sharon A. Minda, Thomas M. Coffman
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 26(3)
The use of cyclosporine (CsA) in renal transplantation has been associated with an improvement in 1-year graft survival, but has not changed the rate of late graft loss. We sought to determine whether the intent to withdraw CsA late after renal trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0427dabb4da34a1dcd60906cdfed4ce
https://pubmed.ncbi.nlm.nih.gov/7645557
https://pubmed.ncbi.nlm.nih.gov/7645557